Telemetry Investments, L.L.C. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 45 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Telemetry Investments, L.L.C. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q4 2022$0
-100.0%
33,3030.0%0.00%
-100.0%
Q3 2022$3,000
-40.0%
33,3030.0%0.00%
-33.3%
Q2 2022$5,000
-28.6%
33,3030.0%0.01%
-45.5%
Q1 2022$7,00033,3030.01%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 200,049$2,007,0000.05%
Q Global Advisors, LLC 195,489$18,0000.01%
RAMIUS ADVISORS LLC 196,073$16,0000.01%
EHP Funds Inc. 137,276$20,0000.00%
Telemetry Investments, L.L.C. 33,303$3,0000.00%
MARSHALL WACE, LLP 190,150$1,930,0000.00%
PERISCOPE CAPITAL INC. 735,572$97,0000.00%
Spartan Fund Management Inc. 75,000$11,0000.00%
Union Square Park Capital Management, LLC 25,000$2,0000.00%
KIM, LLC 250,000$36,0000.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders